Treatment of chronic immune thrombocytopenia in children with romiplostim

Lancet. 2016 Jul 2;388(10039):4-6. doi: 10.1016/S0140-6736(16)00589-4. Epub 2016 Apr 18.

Authors

Shruti Chaturvedi¹, Keith R McCrae²

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
² Department of Hematology and Oncology and Cellular and Molecular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: mccraek@ccf.org.

PMID: 27103125
DOI: 10.1016/S0140-6736(16)00589-4

No abstract available

Publication types

Comment

MeSH terms

Female
Humans
Male
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Receptors, Fc / therapeutic use*
Receptors, Thrombopoietin / agonists*
Recombinant Fusion Proteins / therapeutic use*
Thrombopoietin / therapeutic use*

Substances

Receptors, Fc
Receptors, Thrombopoietin
Recombinant Fusion Proteins
Thrombopoietin